A military whistleblower released a series of documents revealing that the military began “liberally” administering remdesivir to service members who were suspected of having COVID-19 — months before the FDA approved the drug.

A military whistleblower released a series of documents revealing 601 deaths of military service members and a high rate of serious adverse events in clinical trials involving remdesivir, an antiviral commonly administered to COVID-19 patients during the pandemic.